Oct 30, 2024 · Emerging data have shown that BBB dysfunction and inflammation coexist in a vicious cycle in MS and other neurological disorders. BBB disruption and the consequent leakage of blood proteins into ...

Sep 25, 2024 · The 2024 revised criteria will allow diagnosing MS in some patients who would be classified as having radiologically isolated syndrome (RIS), which is defined as the presence of MRI brain lesions ...

Sep 23, 2024 · Moreover, more individuals on tolebrutinib experienced a six-month confirmed disability improvement (CDI), or a sustained reduction in disability scores, compared with the Aubagio group (13.8% ...

Apr 19, 2022 · How are lesions detected in MS? MRI. The gold standard for detecting and monitoring MS lesions in the brain and spinal cord is magnetic resonance imaging, commonly known as MRI.MRI is a non ...

Aug 9, 2024 · Multiple sclerosis (MS) affects each person differently. In relapsing forms of MS, the prognosis is better for women than for men. Compared with men with MS, women tend to have an easier recovery ...

May 19, 2022 · Multiple sclerosis (MS) is an autoimmune disorder in which inflammation causes damage to the nervous system. This can result in a variety of MS symptoms in patients, including muscle spasms and ...

Oct 28, 2024 · Researchers initially detected two lab-made compounds and one plant-derived compound — sulfuretin — that blocked the enzyme’s activity. Sulfuretin was significantly more potent at blocking ...

Nov 4, 2024 · A first group of healthy adults has been dosed in a Phase 1 safety and tolerability trial of Lucid-21-302, a potential myelin-protective oral treatment for multiple sclerosis (MS), regardless of ...

5 days ago · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.

Mar 6, 2024 · The company is in the final stages of safety studies in large animals. Once those studies are done, it plans to start studies that support regulatory applications to move the treatments toward ...